PODCAST · science
NextGen Patient Voice
by Peter Loupos
NextGen Patient Voice explores how research, AI, and public policy are transforming patient advocacy. Each episode breaks down the ideas, tools, and decisions shaping the future of healthcare, with a focus on what they mean for patients, caregivers, and advocates. Clear, practical, and forward-looking, this podcast connects innovation to real-world patient impact.
Episodes
-
Revolutionizing Cancer & Brain Infection Therapies: VCU, UCLA, Colorado, MD Anderson, MeiraGTx
Researchers from VCU Massey, UCLA Health, and the University of Colorado have developed a platform using patient-derived organoids to test cancer therapies. This method allows real-time monitoring of treatment responses, potentially leading to personalized cancer treatments. The University of…
more -
AI in Health, Medicare Bundles, Baptist Health Expands, Device Recalls, and CAR T-Cell Innovations
In this episode, we explore key developments in the healthcare sector. Five leaders in health technology prioritize advancements in AI, while Medicare expands its Comprehensive Care for Joint Replacement Model, marking a significant shift in payment structures. Baptist Health plans to acquire two...
-
CMS Proposes FY 2027 Medicare Updates; AMGA & Talkiatry Partner for Mental Health Access
In this episode, we explore the latest updates in healthcare and medical research. The CMS has proposed Medicare payment increases for skilled nursing facilities, hospices, inpatient rehabilitation, and psychiatric facilities for FY 2027, with a focus on enhancing quality reporting and oversight....
-
Unlocking Asthma Relief: The AIRLYMPUS Study's Quest for Better Breathing Solutions
The AIRLYMPUS Study is investigating a new drug for adults with asthma to see if it can improve breathing, alleviate symptoms, and reduce future attacks when added to standard therapy. Eligible participants are aged 18-80, have had asthma for at least a year, and are on daily treatment. The...
-
"Rare Disease Advocacy, AI in Healthcare, and Novo Nordisk's 340B Oversight: Key Updates"
During Rare Disease Week, families across the nation are advocating for better access to treatments and clinical trials. A Colorado family highlights the challenges faced by rare disease patients after a crucial clinical trial for their son was abruptly terminated, underscoring the need for...
-
Gene Therapy Partnership, CVS GLP-1 Strategy, Moderna's mRNA Settlement, and Health Tech Shifts
In this episode, we explore several key developments in the healthcare and biotech sectors. Cure Rare Disease and the LGMD2L Foundation have partnered to develop a gene therapy for Anoctamin 5-related disease, backed by $7.65 million. This collaboration aims to move a treatment from design to...
-
Unapproved Therapies, Henrietta Lacks Settlement, and At-Home Ketamine: Key Healthcare Updates
Welcome to today's episode, where we delve into the latest developments in the healthcare landscape. First, we explore "Principles for Access to Unapproved Therapies," a document from rarediseases.org that outlines guidelines for accessing unapproved medical treatments for rare diseases. It...
-
Hope in Rare Disease Treatment, Healthcare Cost Innovations, Gene Therapy Breakthroughs, Pharma Trends
In this episode, Judy Stecker shares her journey as a mother of a child with a rare disease, expressing newfound optimism due to advances in medical research and treatment options. She highlights the emotional and financial challenges faced by families, while recent developments offer hope for...
-
Gene Therapy Access, Nemours Home Care, Zocdoc Partnerships, HIV Innovations, Medicaid Fraud Focus
Gene therapy is transforming healthcare with its potential to cure various diseases, yet remains out of reach for many Americans due to high costs and limited availability. Efforts to make these therapies more accessible are ongoing but slow, highlighting the need for systemic healthcare policy...
-
FDA Rejection, Evox-Rett Partnership, AI in Healthcare, Rezatapopt Study, Alzheimer's LLM Framework
In today's episode, we delve into the unexpected FDA rejection of a rare disease drug initially deemed approvable, highlighting the complexities of the drug approval process. We also explore Evox Therapeutics' partnership with the Rett Syndrome Research Trust to develop gene editing therapies…
more
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
NextGen Patient Voice explores how research, AI, and public policy are transforming patient advocacy. Each episode breaks down the ideas, tools, and decisions shaping the future of healthcare, with a focus on what they mean for patients, caregivers, and advocates. Clear, practical, and forward-looking, this podcast connects innovation to real-world patient impact.
HOSTED BY
Peter Loupos
Loading similar podcasts...